[1]
|
Mbijer, J.J., Leonetti, A., Airò, G., et al. (2022) Small Cell Lung Cancer: Novel Treatments beyond Immunotherapy. Seminars in Cancer Biology, 86, 376-385. https://doi.org/10.1016/j.semcancer.2022.05.004
|
[2]
|
陈东方. 广泛期小细胞肺癌基因突变与预后的关系[D]: [博士学位论文]. 上海: 上海交通大学, 2020.
|
[3]
|
Megyesfalvi, Z., Gay, C.M., Popper, H., et al. (2023) Clinical Insights into Small Cell Lung Cancer: Tumor Heterogeneity, Diagnosis, Therapy, and Future Directions. CA: A Cancer Journal for Clinicians, 73, 620-652. https://doi.org/10.3322/caac.21785
|
[4]
|
Megyesfalvi, Z., Tallosy, B., Pipek, O., et al. (2021) The Landscape of Small Cell Lung Cancer Metastases: Organ Specificity and Timing. Thoracic Cancer, 12, 914-923. https://doi.org/10.1111/1759-7714.13854
|
[5]
|
Ko, J., Winslow, M.M. and Sage, J. (2021) Mechanisms of Small Cell Lung Cancer Metastasis. EMBO Molecular Medicine, 13, e13122. https://doi.org/10.15252/emmm.202013122
|
[6]
|
Xiao, Y. and Yu, D. (2021) Tumor Microenvironment as a Therapeutic Target in Cancer. Pharmacology & Therapeutics, 221, Article ID: 107753. https://doi.org/10.1016/j.pharmthera.2020.107753
|
[7]
|
Vitale, I., Manic, G., Coussens, L.M., et al. (2019) Macrophages and Metabolism in the Tumor Microenvironment. Cell Metabolism, 30, 36-50. https://doi.org/10.1016/j.cmet.2019.06.001
|
[8]
|
Niu, X., Chen, L., Li, Y., et al. (2022) Ferroptosis, Necroptosis, and Pyroptosis in the Tumor Microenvironment: Perspectives for Immunotherapy of SCLC. Seminars in Cancer Biology, 86, 273-285. https://doi.org/10.1016/j.semcancer.2022.03.009
|
[9]
|
Li, T. and Qiao, T. (2022) Unraveling Tumor Microenvironment of Small-Cell Lung Cancer: Implications for Immunotherapy. Seminars in Cancer Biology, 86, 117-125. https://doi.org/10.1016/j.semcancer.2022.09.005
|
[10]
|
Petty, W.J. and Paz-Ares, L. (2023) Emerging Strategies for the Treatment of Small Cell Lung Cancer: A Review. JAMA Oncology, 9, 419-429. https://doi.org/10.1001/jamaoncol.2022.5631
|
[11]
|
Yin, X., Li, Y., Wang, H., et al. (2022) Small Cell Lung Cancer Transformation: From Pathogenesis to Treatment. Seminars in Cancer Biology, 86, 595-606. https://doi.org/10.1016/j.semcancer.2022.03.006
|
[12]
|
Chan, J.M., Quintanal-Villalonga, Á., Gao, V.R., et al. (2021) Signatures of Plasticity, Metastasis, and Immunosuppression in An Atlas of Human Small Cell Lung Cancer. Cancer Cell, 39, 1479-1496. https://doi.org/10.1016/j.ccell.2021.09.008
|
[13]
|
Tungsukruthai, S., Sritularak, B. and Chanvorachote, P. (2017) Cycloartobiloxanthone Inhibits Migration and Invasion of Lung Cancer Cells. Anticancer Research, 37, 6311-6319.
|
[14]
|
Liang, H., Zhang, L., Zhao, X., et al. (2023) The Therapeutic Potential of Exosomes in Lung Cancer. Cellular Oncology, 46, 1181-1212. https://doi.org/10.1007/s13402-023-00815-8
|
[15]
|
Yuan, M., Zhao, Y., Arkenau, H.T., et al. (2022) Signal Pathways and Precision Therapy of Small-Cell Lung Cancer. Signal Transduction and Targeted Therapy, 7, Article No. 187. https://doi.org/10.1038/s41392-022-01013-y
|
[16]
|
Marcoux, N., Gettinger, S.N., O’Kane, G., et al. (2019) EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes. Journal of Clinical Oncology, 37, 278-285. https://doi.org/10.1200/JCO.18.01585
|
[17]
|
Pan, J., Fang, S., Tian, H., et al. (2020) LncRNA JPX/MiR-33a-5p/Twist1 Axis Regulates Tumorigenesis and Metastasis of Lung Cancer by Activating Wnt/β-Catenin Signaling. Molecular Cancer, 19, Article No. 9. https://doi.org/10.1186/s12943-020-1133-9
|
[18]
|
Li, D., Tong, Q., Lian, Y., et al. (2021) Inhibition of LncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition. Cancer Research and Treatment, 53, 1042-1056. https://doi.org/10.4143/crt.2020.1208
|
[19]
|
Rudin, C.M., Brambilla, E., Faivre-Finn, C., et al. (2021) Small-Cell Lung Cancer. Nature Reviews Disease Primers, 7, Article No. 3. https://doi.org/10.1038/s41572-020-00235-0
|
[20]
|
George, J., Lim, J.S., Jang, S.J., et al. (2015) Comprehensive Genomic Profiles of Small Cell Lung Cancer. Nature, 524, 47-53. https://doi.org/10.1038/nature14664
|
[21]
|
Sivakumar, S., Moore, J.A., Montesion, M., et al. (2023) Integrative Analysis of a Large Real-World Cohort of Small Cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation. Cancer Discovery, 13, 1572-1591. https://doi.org/10.1158/2159-8290.CD-22-0620
|
[22]
|
Febres-Aldana, C.A., Chang, J.C., Ptashkin, R., et al. (2022) Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset. Clinical Cancer Research, 28, 4702-4713. https://doi.org/10.1158/1078-0432.CCR-22-1115
|
[23]
|
Ireland, A.S., Micinski, A.M., Kastner, D.W., et al. (2020) MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate. Cancer Cell, 38, 60-78. https://doi.org/10.1016/j.ccell.2020.05.001
|
[24]
|
Pongor, L.S., Schultz, C.W., Rinaldi, L., et al. (2023) Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes. Cancer Discovery, 13, 928-949. https://doi.org/10.1158/2159-8290.CD-22-0796
|
[25]
|
Wang, L., Chen, C., Song, Z., et al. (2022) EZH2 Depletion Potentiates MYC Degradation Inhibiting Neuroblastoma and Small Cell Carcinoma Tumor Formation. Nature Communications, 13, Article No. 12. https://doi.org/10.1038/s41467-021-27609-6
|
[26]
|
Yin, X., Yang, J., Wang, H., et al. (2022) Non-Coding Genome in Small Cell Lung Cancer between Theoretical View and Clinical Applications. Seminars in Cancer Biology, 86, 237-250. https://doi.org/10.1016/j.semcancer.2022.03.024
|
[27]
|
Ghafouri-Fard, S., Shoorei, H., Branicki, W., et al. (2020) Non-Coding RNA Profile in Lung Cancer. Experimental and Molecular Pathology, 114, Article ID: 104411. https://doi.org/10.1016/j.yexmp.2020.104411
|
[28]
|
Hamilton, G. and Rath, B. (2015) Smoking, Inflammation and Small Cell Lung Cancer: Recent Developments. Wiener Medizinische Wochenschrift, 165, 379-386. https://doi.org/10.1007/s10354-015-0381-6
|
[29]
|
Rath, B., Plangger, A., Klameth, L., et al. (2023) Small Cell Lung Cancer: Circulating Tumor Cell Lines and Expression of Mediators of Angiogenesis and Coagulation. Exploration of Targeted Anti-Tumor Therapy, 4, 355-365. https://doi.org/10.37349/etat.2023.00139
|
[30]
|
Zheng, Y., Wang, L., Yin, L., et al. (2022) Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies. Frontiers in Oncolog, 12, Article 873994. https://doi.org/10.3389/fonc.2022.873994
|
[31]
|
Lim, J.S., Ibaseta, A., Fischer, M.M., et al. (2017) Intratumoural Heterogeneity Generated by Notch Signalling Promotes Small-Cell Lung Cancer. Nature, 545, 360-364. https://doi.org/10.1038/nature22323
|
[32]
|
Schneider, B.J. and Kalemkerian, G.P. (2016) Personalized Therapy of Small Cell Lung Cancer. In: Ahmad, A. and Gadgeel, S., Eds., Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management, Springer, Cham, 149-174. https://doi.org/10.1007/978-3-319-24932-2_9
|
[33]
|
Plaja, A., Moran, T., Carcereny, E., et al. (2021) Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack? International Journal of Molecular Sciences, 22, Article 13508. https://doi.org/10.3390/ijms222413508
|
[34]
|
Khan, P., Siddiqui, J.A., Kshirsagar, P.G., et al. (2023) MicroRNA-1 Attenuates the Growth and Metastasis of Small Cell Lung Cancer through CXCR4/FOXM1/RRM2 Axis. Molecular Cancer, 22, Article No. 1. https://doi.org/10.1186/s12943-022-01695-6
|
[35]
|
Pellini, B. and Chaudhuri, A.A. (2023) CtDNA Monitoring for Small Cell Lung Cancer: Ready for Prime Time? Clinical Cancer Research, 29, 2176-2178. https://doi.org/10.1158/1078-0432.CCR-23-0420
|
[36]
|
Wang, Y., Zou, S., Zhao, Z., et al. (2020) New Insights into Small-Cell Lung Cancer Development and Therapy. Cell Biology International, 44, 1564-1576. https://doi.org/10.1002/cbin.11359
|
[37]
|
Bogart, J.A., Waqar, S.N. and Mix, M.D. (2022) Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer. Journal of Clinical Oncology, 40, 661-670. https://doi.org/10.1200/JCO.21.01639
|
[38]
|
Yang, S., Zhang, Z. and Wang, Q. (2019) Emerging Therapies for Small Cell Lung Cancer. Journal of Hematology & Oncology, 12, Article No. 47. https://doi.org/10.1186/s13045-019-0736-3
|
[39]
|
Zugazagoitia, J. and Paz-Ares, L. (2022) Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options. Journal of Clinical Oncology, 40, 671-680. https://doi.org/10.1200/JCO.21.01881
|
[40]
|
Wang, W.Z., Shulman, A., Amann, J.M., et al. (2022) Small Cell Lung Cancer: Subtypes and Therapeutic Implications. Seminars in Cancer Biology, 86, 543-554. https://doi.org/10.1016/j.semcancer.2022.04.001
|